Bluejay Diagnostics, Inc. Accrued Liabilities, Current
Bluejay Diagnostics, Inc. (BJDX) had Accrued Liabilities, Current of $804.94 thousand as of 2025-12-31, per its 10-K filed 2026-03-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-03-06
- 2025-12-31: Accrued Liabilities, Current $804.94K.
- 2024-12-31: Accrued Liabilities, Current $551.99K.
- 2024-03-31: Accrued Liabilities, Current $1.11M.
- 2023-12-31: Accrued Liabilities, Current $1.12M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2025-12-31 | $804.94K 10-K · filed 2026-03-06 | |
| 2024-12-31 | $551.99K 10-K · filed 2026-03-06 | |
| 2024-03-31 | $1.11M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $1.12M 10-K · filed 2025-03-31 | |
| 2023-06-30 | $1.39M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $863.40K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $835.73K 10-K · filed 2024-03-28 | |
| 2022-09-30 | $1.08M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $783.48K 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $592.62K 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $341.38K 10-K · filed 2023-03-20 | $339.38K 10-K · filed 2022-03-10 |
| 2021-09-30 | $371.29K 10-Q · filed 2021-12-16 | |
| 2020-12-31 | $133.82K 10-K · filed 2022-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |